Reconstructive Surgery Market Trends Growth Insights 2023-2030
Reconstructive surgery market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 7.8% during the forecast period (2023-2030). Reconstructive surgery treats aesthetically functionally affected body structures from congenital defects, trauma, infection, developmental abnormalities, tumors or disease. These surgeries improve the dramatic structure's function and ability and achieve a more typical appearance, and recovery from reconstructive surgery takes about 6-8 weeks.
Reconstructive Surgery - Market Dynamics
Advancement in reconstructive surgery is expected to drive market growth.
Modern medicine has made great progress in tissue and organ restoration over the years. For instance, if a car accident victim needs a reconstructed jaw, doctors make it using a piece of the patient's fibula bone and the surrounding soft tissue and blood arteries, a method known as autografting. Autografting is extremely taxing on the body and frequently results in medical issues. A Technion-Israel Institute of Technology team created blood arteries for improved tissue remodeling and healing using stem cells produced from dental pulp (the soft tissue within the tooth) and capillary-forming endothelial cells. Therefore, patients could obtain a lab-grown bone that perfectly matches the contour of their face, surrounded by lab-grown soft tissues based on their cells developed using 3D biomaterials, employing these procedures. There would be no need to harm the patient's other body components. Thus, the market is expected to drive in the forecast period from the above statements.
Reconstructive Surgery Market Report Statistics
|
Metrics |
Details |
|
Market CAGR |
7.8% |
|
Segments Covered |
By Indication, By Prosthetic Implant, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Restraint:
Few Risks are associated with reconstructive surgery, including Problems with anesthesia, bleeding, blood clots, infection, healing problems and fatigue (tiredness). Moreover, the high price of devices & implants and preference for drugs over treatment devices are some factors that the market is expected to hamper in the forecast period.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. The first wave of pandemic demand saw a rush on facial procedures in response to a significant increase in Zoom calls and downtime for discreet recovery at home. Meanwhile, plastic surgeons have postponed their appointments due to the equitable and reasonable distribution of medical supplies. Postponing non-delayable operations might have a negative impact on the patient's health and quality of life. Furthermore, a very long waiting list is being created for the foreseeable future, with patients being prioritized based on their clinical status. Some patients with benign but potentially malignant conditions will delay their procedures due to this prioritization process. Thus, the market will undergo impetus during the forecast period.
Reconstructive Surgery Market Segment Analysis
The breast Reconstruction segment is expected to hold the largest market share in the global market for reconstructive surgery.
By Indication:
- Breast Reconstruction
- Congenital Anomalies
- Orthognathic Surgeries
- Hand Surgery
- Tissue Expansion
- Facial reconstruction
- Limb salvage
- Others
By Prosthetic Implant:
- Tubes
- Rings
- Stents
- Implants
- Others
By End-User:
- Hospitals
- Ambulatory Surgical Units
- Dermatology Clinics
- Others
The breast reconstruction segment accounted for the largest market share in 2020. The segment benefits because it minimizes pain and allows for a faster recovery than typical reconstruction that involves implanting or expanding tissue on top of the pectoral muscles. For instance, A pre-pectoral treatment is the least invasive breast reconstruction option. A mastectomy is a procedure in which the doctor removes breast tissue through a tiny incision beneath the breast. A tissue expander is put on top of the muscle to produce a breast mound through this incision. Next, the doctor removes the expander and installs an implant through the same incision.
Moreover, breast implants are used in the majority of breast reconstruction treatments. Saline or silicone implants are implanted behind the pectoral muscles in this classic reconstructive method, forcing them to stretch to fit the implants. Many people benefit from this procedure; however, many women report shoulder pain and limited range of motion. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.
Geographical Analysis
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
- Rest of the world
North America region holds the largest market share in the global reconstructive surgery market
North America accounted for the highest revenue share in 2020. Increasing prevalence of cancer, incidence of spine disorders, rising prevalence of geriatric population, Patient awareness initiatives, advanced health care infrastructure with current software modalities and high per capita health care expense and early-stage diagnosis, and less strict regulation of reconstruction surgery instruments are some of the factors due to which the market is expected to boost in the forecast period.
For instance, Breast cancer can be linked to known gene mutations inherited from one's mother or father in about 5-10% of cases. The most prevalent mutations are in the BRCA1 and BRCA2 genes. Women with a BRCA1 mutation have a lifetime chance of developing breast cancer of up to 72 percent. The risk is 69 percent for women who have a BRCA2 mutation. Breast cancer in women with BRCA1 or BRCA2 mutations is more common in younger women. These genetic alterations are also linked to an increased risk of ovarian cancer.
Moreover, for women in the U.S., breast cancer death rates are higher than those for any other cancer besides lung cancer; about 1 in 8 U.S. women (about 13%) will develop invasive breast cancer throughout their lifetime. Additionally, as of January 2022, there are more than 3.8 million women with a history of breast cancer in the U.S. This includes women currently being treated and women who have finished treatment. Therefore, it has increased the demand for reconstructive surgery, due to which the North American region is expected to hold the largest market share in the forecast period.
Some of the Major Companies Covered:
- Johnson and Johnson
- Merz Pharma
- Bausch Health Companies Inc
- Baxter
- Accurate Surgical & Scientific Instruments Corporation
- Silimed, Inc.
- Sebbin and KOKEN CO., LTD.
Johnson and Johnson:
Johnson & Johnson is an American multinational corporation. The company is into medical devices, pharmaceuticals, and consumer packaged goods. Johnson & Johnson's brands include more household names of medications and first aid supplies. Its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnsons Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash, and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutical.
Product Portfolio:
MENTOR: The MENTOR Collection of Breast Implants are indicated for breast reconstruction.
